Segurado OG[au] - Search Results

Year	Number of Results
1986	1
1987	1
1988	2
1989	2
1990	4
1991	5
1992	4
1993	8
1997	1
2005	2
2006	4
2007	2
2008	1
2009	1
2012	1
2013	1
2014	1
2015	2
2016	1
2021	1
2022	2

1

Genome ethics treaty.

Segurado OG, Schendel DJ. Segurado OG, et al. Nature. 1991 Aug 1;352(6334):368. doi: 10.1038/352368a0. Nature. 1991. PMID: 1861714 No abstract available.

2

Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis.

Segurado OG, Sasso EH. Segurado OG, et al. Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-29-34. Epub 2014 Oct 30. Clin Exp Rheumatol. 2014. PMID: 25365086 Review.

3

Discrepancy Between Multibiomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis.

Fleischmann R, Liu J, Zhu J, Segurado OG, Furst DE. Fleischmann R, et al. Among authors: segurado og. Arthritis Care Res (Hoboken). 2021 Feb 28. doi: 10.1002/acr.24583. Online ahead of print. Arthritis Care Res (Hoboken). 2021. PMID: 33644992

4

HUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab.

Kivitz A, Segurado OG. Kivitz A, et al. Among authors: segurado og. Expert Rev Med Devices. 2007 Mar;4(2):109-16. doi: 10.1586/17434440.4.2.109. Expert Rev Med Devices. 2007. PMID: 17359217 Review.

5

Hemophilia A gene therapy: current and next-generation approaches.

Pipe SW, Gonen-Yaacovi G, Segurado OG. Pipe SW, et al. Among authors: segurado og. Expert Opin Biol Ther. 2022 Jan 6:1-17. doi: 10.1080/14712598.2022.2002842. Online ahead of print. Expert Opin Biol Ther. 2022. PMID: 34781798

6

Acquired selective signature dysgraphia.

Regueiro AM, Segurado OG, Mata P, Regueiro JR. Regueiro AM, et al. Among authors: segurado og. Ann Neurol. 1992 Jan;31(1):115. doi: 10.1002/ana.410310126. Ann Neurol. 1992. PMID: 1543344 No abstract available.

7

The multifactorial nature of MHC-linked susceptibility to insulin-dependent diabetes.

Segurado OG, Arnaiz-Villena A, Wank R, Schendel DJ. Segurado OG, et al. Autoimmunity. 1993;15(1):85-9. doi: 10.3109/08916939309004844. Autoimmunity. 1993. PMID: 8218835 Review.

8

Performance of a novel BD stem cell enumeration kit on two flow cytometry systems.

Omana-Zapata I, Oreizy F, Mosqueda F, Salemenik M, Lin A, Wen JL, Varro R, Lee-Haynes L, Segurado OG. Omana-Zapata I, et al. Among authors: segurado og. Int J Lab Hematol. 2013 Aug;35(4):393-9. doi: 10.1111/ijlh.12029. Epub 2012 Nov 28. Int J Lab Hematol. 2013. PMID: 23190563

9

Challenges and opportunities when transitioning from in vivo gene replacement to in vivo CRISPR/Cas9 therapies - a spotlight on hemophilia.

Segurado OG, Jiang R, Pipe SW. Segurado OG, et al. Expert Opin Biol Ther. 2022 Jun 21:1-8. doi: 10.1080/14712598.2022.2090241. Online ahead of print. Expert Opin Biol Ther. 2022. PMID: 35708146

10

Early predictors of prognosis in Guillain-Barré syndrome.

Segurado OG, Arnaiz-Villena A. Segurado OG, et al. Lancet. 1988 Dec 10;2(8624):1365-6. doi: 10.1016/s0140-6736(88)90901-4. Lancet. 1988. PMID: 2904080 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results